US HB238: Healthy Technology Act of 2025 Reviewed

The Healthy Technology Act of 2025 seeks to amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence (AI) and machine learning (ML) technologies can qualify as practitioners eligible to prescribe drugs. This qualification requires that these technologies be both approved, cleared, or authorized by the Food and Drug Administration (FDA) and authorized by the state involved. The use of 'and' in the official description implies that both conditions must be met simultaneously. The bill also mentions 'other purposes,' but without the full text, these purposes remain unspecified and cannot be analyzed further. Due to the lack of full text, it is not possible to confirm whether the bill addresses data privacy or interoperability standards. As a federal initiative, the bill's scope may influence how state authorization is interpreted.